Chemical enhancers for transdermal drug transport

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 1-2, 2001, Pages 85-94

  Bauerova K ^a   Matusova D ^b   Kassai, Z ^c  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Drug Research Institute   (Slovakia)

^c SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

Chemical; Drug delivery; Enhancers; Permeation; Transdermal

Indexed keywords

ALCOHOL; AMIDE; AMINE; DRUG; ESTER; FATTY ACID; MACROCYCLIC COMPOUND; POLYOL; SULFOXIDE; TERPENE; TOPICAL AGENT;

ARTICLE; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; SKIN PERMEABILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; HUMANS; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION; SKIN PHYSIOLOGY; STIMULATION, CHEMICAL;

EID: 0034873593     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190381     Document Type: Article

References (112)

1. Evaluation and prediction of drug permeation
2. Percutaneous absorption-transepidermal water loss relationship in man in vivo
3. Modelling percutaneous drug transport; the interplay between water, flux enhancers and skin lipids
4. Factors affecting the formation, morphology and permeability of stratum corneum lipid bilayers in vitro
5. Transdermal delivery of contraceptives
6. Essential fatty acids and epidermal integrity
7. Correlation between stratum corneum reservoir function and percutaneous absorption
8. Permeability of the skin
9. Percutaneous absorption of drugs in vitro: Role of transepidermal and transfollicular routes
10. Regional variation of percutaneous absorption in man: Measurement by the stripping method
11. Structural alterations in exposed and unexposed aged skin
12. Aging significantly decreases the capacity of human epidermis to produce vitamin D3
13. Immediate skin-test reactivity in a general population sample
14. Methods for in vitro percutaneous absorption studies: Use of excised human skin
15. In vivo biophysical characterization of skin physiological differences in races
16. Transdermal drug delivery: Problems and possibilities
17. Application of drugs in transdermal therapeutic systems
18. Transdermal enhancer patent literature
19. In vitro evaluation of transdermal penetration enhancers for moxonidine
20. Recent progress in protein and peptide delivery by noninvasive routes
21. Percutaneous penetration enhancers: The fundamentals
22. Skin absorption enhancers
23. How to optimize drug penetration through the skin
24. In vitro and in vivo evaluation of the effect of barrier gels in nickel contact allergy
25. Analysis of skin penetration enhancement based on two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: Dose-dependent effect of 1-geranylaza-cycloheptan-2-one on drugs with different lipophilicities
26. Mechanism and reversibility of penetration enhancer action in the skin - A DSC study
27. Mechanism and enhancement of skin permeation in vivo
28. Use of human keratinocyte and fibroblast cultures for toxicity studies of topically applied compounds
29. Penetration enhancer classification
30. Modulation der wirkstoffpenetration in die haut
31. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structual changes in the presence of short chain alcohols
32. Influence of composition of 1-menthol-ethanol-water ternary solvent sysytem on the transdermal delivery of morphine hydrochloride
33. Effect of various vehicles on ketoprofen permeation across excised hairless mouse skin
34. Swelling of PHEMA based membranes in ethanol and their nitroglycerin permeabilities
35. Solvent drug in ethyl acetate/ethanol-enhanced skin permeation
36. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II: Drug, vehicle, and enhancer penetration kinetics
37. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: Effect of enhancer lipophilicity
38. Penetration of Sandimune (cyclosporin A) in rat skin in vitro. Effect of penetration enhancers and solvents
39. Immunomodulation of psoriasis with topical cyclosporin A formulation
40. Percutaneous absorption of 2′, 3′-didioxyinosine in rat
41. The single-pass perfused rabbit ear as a model for studying percutaneous absorption of clonazepan II. Influence of hydrogel-borne propylene glycol and skin pretreatment with lauryl alcohol
42. Effect of several penetration enhancers of the percutaneous absorption of indomethacin in hairless rats
43. Esters of omega-amino acids aflexible penetration enhancers
44. Epsilon-aminocapronic acid esters as transdermal penetration enhancing agents
45. In vitro evaluation of a series of azone® analoges as dermal penetration enhancers. III. Acyclic amides
46. Facilitated transport of two model steroids by esters and amides of clofibric acid
47. Mechanism of skin penetration-enhancing effect by laurocapram
48. Percutaneous absorption of azone following single and multiple doses to human volunteers
49. Percutaneous absorption, metabolic profiling, and excretion of the penetration enhancer azone after multiple dosing of an azone-containing triamcinolone acetonide cream in humans
50. Disposition and metabolic profiling of the penetration enhancer azone. I. In vitro studies: Urinary profiles of hamster, rat, monkey, and man
51. Percutaneous penetration of acyclovir through excised hairless mouse and rat skin: Effect of vehicle and percutaneous penetration enhancer
52. Use of derivative UV spectroscopy to monitor the percutaneous absorption of befunolol-HCL
53. Measuring the uptake of azone into excised human stratum corneum from thin polymer film
54. Keratinized epithelial transport of beta-blocking agents. Evaluation of enhancing effect on percutaneous absorption using model lipid liposomes
55. Permeation of a pyridoindol structure substance from the transcutol®/water/azone® cosolvent system
56. The effect of azone on penetration of pyridoindole acylderivatives across 5-day rat skin
57. Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: Optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101
58. Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101)
59. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: Combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers
60. Effect of 1-alkyl- or 1-alkenylazacycloalkanone derivatives on the penetration of drugs with different lipophilicities through guinea pig skin
61. Comparative analysis of percutaneous absorption enhancement by d-limonene and oleic acid based on a skin diffusion model
62. In vivo and in vitro analysis of skin penetration enhancement based on two-layer diffusion model with polar and nonpolar routes in stratum corneum
63. Skin penetration enhancement of acyclovir by prodrug-enhancer combination
64. Application of in vivo microdialysis to transdermal absorption of methotrexate in rats
65. In vivo microdialysis for the transdermal absorption of valporate in rats
66. Pyrrolidones as penetration enhancers
67. Mechanistic studies of the 1-alky-2-pyrrolidones as skin permeation enhancers
68. Topically applied antibiotics in acne vulgaris
69. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen
70. Preparation of alkyl-substituted pyrrolidone derivatives and their evaluation as transdermal penetration enhancers
71. Enhancing effect of pyrrolidone derivatives on transdermal penetration of phenolsulfonphthalein and indomethacin from aqueous vehicle
72. Enhancing effect of pyrrolidone derivatives on the transdermal penetration of sulfaguanidine, aminopyrine and Sudan III
73. Effect of pyrrolidone derivatives on lipid membrane and protein conformation as transdermal penetration enhancer
74. Acute toxicity and skin irritation of pyrrolidone derivatives as transdermal penetration enhancer
75. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes
76. Influence of limonene and laurocapram on percutaneous absorption of nonsteroidal anti-inflammatory drugs
77. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement
78. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil
79. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement
80. Formulation optimisation of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers
81. Percutaneous absorption of physiologically active peptides, ebiratide and alcatonin, in rats
82. Effect of 1-menthol on the permeation of indomethacin, mannitol and cortisone through excised hairless mouse skin
83. Contribution of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amine
84. Percutaneous enhancement of leuroprolide
85. Percutaneous penetration enhancers: Mode of action
86. Evidence that oleic acid exists in a separate phase within stratum corneum lipids
87. Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy
88. Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles
89. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines
90. Effect of monoglycerides on the percutaneous absorption of papaverine hydrochloride
91. Transdermal delivery of physistigmine. A pretreatment against organophosphate poisoning
92. Transdermal delivery of ketorolac tromethamine: Permeation enhancement device design amd pharmacokinetics in heathy humans
93. The effect of penetration enhancers on transdermal transport of propanolol hydrochloride (PH)
94. Dispraty of in vitro and in vivo oleic acid-enhanced beta-estradiol percutaneous absorption across human skin
95. Freeze-fracture electron microscopic and osmotic water permeability studies of epidermal lipid liposomes derived from stratum corneum lipids of porcine epidermis
96. Effect of hydrophilic and lipophilic vehicles on skin permeation of tegafur, alclofenac and ibuprofen with or without permeation enhancers
97. Relationship between lipophilicity and skin permeability of various drugs from an ethanol/water/lauric acid system
98. A study of the percutaneous absorption-enhancers effect of cyclodextrin derivatives in rats
99. The effect cyclodextrines on percutaneous transport of drugs
100. Dimethylsulfoxide
101. Influence of irritants lymph node cell proliferation and the detection of contact sensitivity to metal salts in the murine local lymph node assay
102. Contact hypersensitivity to hydrocortisone-free alcohol in patients with allergic patch test reactions to tixocoitol pivalate
103. Enhancement of the in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer
104. Some general influences of n-decylmethyl sulfoxide on the permeation of drugs across hairless mouse skin
105. Transdermal delivery of bioactive peptides: The effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport
106. Surfactans
107. Transdermal delivery of drugs with differing lipophilicity using azone analogs as dermal penetration enhancers
108. Mechanism of the enhancement effect of n-octyl-beta-D-thio-glucoside on the transdermal penetration of fluorescein isothiocyanate-labeled dextrans and the molecular weight dependence of water-soluble penetrants though stripped skin
109. Enhancing effects of lipophilic vehicles on skin penetration of methyl nicotinate in vivo
110. An attampt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry (DSC)